semaglutide 503b As of February 21, 2025, the FDA updated its drug shortage list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A FDA moves against compounding glp1's

We expect that additional healthcare reform measures will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, and in turn could significantly reduce the projected value of certain development projects and reduce our profitability

Foundayo is currently the most accessible in the GLP-1 class at $149 per month for self-pay patients, with insured patients potentially paying as little as $25 per month

Modo de uso

What's better for weight loss, Mounjaro or Ozempic

And it creates a consistent routine that supports medication adherence

With expert guidance from the Physique26 team, each product is selected to align with your unique goals, ensuring optimal results